| A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 508 | 2016 |
| Cytogenetic risk stratification in chronic myelomonocytic leukemia E Such, J Cervera, D Costa, F Solé, T Vallespí, E Luño, R Collado, ... Haematologica 96 (3), 375, 2011 | 301 | 2011 |
| Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome G Sanz, B Nomdedeu, E Such, T Bernal, M Belkaid, MT Ardanaz, V Marco, ... Blood 112 (11), 640, 2008 | 165 | 2008 |
| Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective K Fischer, P Poonnoose, AL Dunn, P Babyn, MJ Manco‐Johnson, ... Haemophilia 23 (1), 11-24, 2017 | 76 | 2017 |
| Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale S Bonanad, J De la Rubia, M Gironella, EP Persona, B González, ... Journal of geriatric oncology 6 (5), 353-361, 2015 | 72 | 2015 |
| Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm J Batlle, A Pérez-Rodríguez, I Corrales, MF López-Fernández, ... Thrombosis and haemostasis 115 (01), 40-50, 2016 | 69 | 2016 |
| Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A M García‐Dasí, JA Aznar, V Jiménez‐Yuste, C Altisent, S Bonanad, ... Haemophilia 21 (4), 458-464, 2015 | 68 | 2015 |
| Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants JA Aznar, S Bonanad, JM Montoro, C Hurtado, AR Cid, MA Soler, ... Vox sanguinis 79 (3), 156-160, 2000 | 64 | 2000 |
| Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis … JA Lopez-Guerrero, PB Gilabert, EB Gonzalez, MAS Alonso, JP Perez, ... Journal of hematotherapy 8 (1), 53-61, 1999 | 51 | 1999 |
| Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis F Peyvandi, A Cannavò, I Garagiola, R Palla, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (1), 39-43, 2018 | 49 | 2018 |
| Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients N Borràs, J Batlle, A Pérez-Rodríguez, MF López-Fernández, ... Haematologica 102 (12), 2005, 2017 | 42 | 2017 |
| Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R) II) C Hurtado, S Bonanad, MF Soler, V Mirabet, I Blasco, M Planelles, ... Haematologica 85 (4), 390-395, 2000 | 38 | 2000 |
| Prolonged molecular remission after PML/RARα-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal … MA Sanz, J De la Rubia, S Bonanad, E Barragan, A Sempere, G Martin, ... Leukemia 12 (6), 992-995, 1998 | 37 | 1998 |
| Source of factor VIII replacement (plasmatic or recombinant) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the … F Peyvandi, PM Mannucci, I Garagiola, M Elalfy, A El-Beshlawy, ... Blood 126 (23), 5, 2015 | 36 | 2015 |
| The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome I Cordoba, JR Gonzalez-Porras, E Such, B Nomdedeu, E Luño, R De Paz, ... Leukemia research 36 (3), 287-292, 2012 | 36 | 2012 |
| Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A JE Megías-Vericat, S Bonanad, S Haya, AR Cid, MR Marqués, E Monte, ... Thrombosis research 174, 151-162, 2019 | 33 | 2019 |
| Safety and effectiveness of progressive moderate-to-vigorous intensity elastic resistance training on physical function and pain in people with hemophilia J Calatayud, S Pérez-Alenda, JJ Carrasco, C Cruz-Montecinos, ... Physical therapy 100 (9), 1632-1644, 2020 | 31 | 2020 |
| Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement S Spena, I Garagiola, A Cannavò, M Mortarino, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (4), 778-790, 2018 | 31 | 2018 |
| Increase of neutrophil activation markers in venous thrombosis—Contribution of circulating activated protein C L Martos, J Oto, Á Fernández-Pardo, E Plana, MJ Solmoirago, F Cana, ... International Journal of Molecular Sciences 21 (16), 5651, 2020 | 28 | 2020 |
| HLA‐DQA,‐DQB and‐DRB allele contribution to narcolepsy susceptibility D Planelles, N Puig, A Beneto, E Gomez, P Rubio, V Mirabet, S Bonanad, ... European journal of immunogenetics 24 (6), 409-421, 1997 | 28 | 1997 |
